Epinephrine can temporarily exacerbate the ... These limitations include fear of the needle, lack of portability, needle-related safety concerns, lack of reliability, and complexity of the devices.

T he US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as ...

“If approved, neffy would represent the first-ever needle-free nasal spray epinephrine treatment for people with severe allergic reactions that has been shown to be more easily carried and ...

Those who rely on EpiPens during an allergic reaction may have a new alternative to reach for, after the U.S. Food and Drug ...

Oppenheimer initiated coverage of ARS Pharmaceuticals (SPRY) with an Outperform rating and $40 price target As the first and only approved ...